Health Portal - Answers, One Place

Government launches fund to boost biotech growth

by Nabila Anuar • -378 minutes ago

Panel urges health ministry to study Ayush drug costs

by Beatrice Gray • 18 hours ago

BMS reports positive Phase II data for relapsed multiple myeloma

by Beatrice Gray • 1 day ago

Clover’s combo vaccine passes Phase II in seniors

by Beatrice Gray • 2 days ago

Symptom Checker

Specialist Directory

BMS reports positive Phase II data for relapsed multiple myeloma

by Beatrice Gray • 1 day ago

Specialist Directory

Clover’s combo vaccine passes Phase II in seniors

by Beatrice Gray • 2 days ago

Specialist Directory

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

by Beatrice Gray • 4 days ago

Specialist Directory

First patient receives BHB810 in BigHat study

by Nabila Anuar • Sep 2, 2026

Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 6 days ago

Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings

by Rina Raha • Aug 31, 2026

Lab Explainers

Ocugen starts trial of new eye treatment

by Nabila Anuar • Sep 3, 2026

HiRO partners with Differentia Biotech for trial simulation

by Beatrice Gray • Aug 31, 2026

BETTER LIVING

Clover’s combo vaccine passes Phase II in seniors

By Beatrice Gray • 2 days ago

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

By Beatrice Gray • 4 days ago

Arlo points to promising Phase II data for swelling disorder drug

By Nabila Anuar • 5 days ago

ALL POST

Symptom Checker

Government launches fund to boost biotech growth

by Nabila Anuar • -378 minutes ago

Symptom Checker

Panel urges health ministry to study Ayush drug costs

by Beatrice Gray • 18 hours ago

Specialist Directory

BMS reports positive Phase II data for relapsed multiple myeloma

by Beatrice Gray • 1 day ago

Specialist Directory

Clover’s combo vaccine passes Phase II in seniors

by Beatrice Gray • 2 days ago

Specialist Directory

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

by Beatrice Gray • 4 days ago

Symptom Checker

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 5 days ago

Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 6 days ago

Lab Explainers

Ocugen starts trial of new eye treatment

by Nabila Anuar • Sep 3, 2026

Specialist Directory

First patient receives BHB810 in BigHat study

by Nabila Anuar • Sep 2, 2026

Symptom Checker

Jazz reports interim Phase III results for Ziihera

by Nabila Anuar • Sep 1, 2026

Government launches fund to boost biotech growth

Panel urges health ministry to study Ayush drug costs

BMS reports positive Phase II data for relapsed multiple myeloma

Clover’s combo vaccine passes Phase II in seniors

Symptom Checker

Specialist Directory

BMS reports positive Phase II data for relapsed multiple myeloma

Clover’s combo vaccine passes Phase II in seniors

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

First patient receives BHB810 in BigHat study

MOST READ

LATEST NEWS

Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings

Lab Explainers

Ocugen starts trial of new eye treatment

BETTER LIVING

Clover’s combo vaccine passes Phase II in seniors

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Arlo points to promising Phase II data for swelling disorder drug

ALL POST

Government launches fund to boost biotech growth

Panel urges health ministry to study Ayush drug costs

BMS reports positive Phase II data for relapsed multiple myeloma

Clover’s combo vaccine passes Phase II in seniors

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Arlo points to promising Phase II data for swelling disorder drug

Sensorion Wins Approval for HearConnex Trial in France

Ocugen starts trial of new eye treatment

First patient receives BHB810 in BigHat study

Jazz reports interim Phase III results for Ziihera

Latest Post

About

Social Media